Announcements Trials

Browse Landscape

Phase

Phase NA 5 Phase 4 1 Phase 3 1 Phase 2 1 Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 234 Breast Neoplasms 234 Prostatic Neoplasms 172 Multiple Myeloma 154 Neoplasms 135 Colorectal Neoplasms 126 Leukemia, Myeloid, Acute 123 Lung Neoplasms 109 Neoplasm Metastasis 101 Squamous Cell Carcinoma of Head and Neck 94 Carcinoma, Hepatocellular 91 Melanoma 89 Lymphoma 85 Triple Negative Breast Neoplasms 77 Pancreatic Neoplasms 76 Ovarian Neoplasms 72 Sarcoma 71 Brain Neoplasms 66 Lymphoma, Large B-Cell, Diffuse 65 Carcinoma, Renal Cell 65 Recurrence 63 Precursor Cell Lymphoblastic Leukemia-Lymphoma 60 Head and Neck Neoplasms 56 Lymphoma, Non-Hodgkin 55 Leukemia, Lymphocytic, Chronic, B-Cell 55 Stomach Neoplasms 52 Hematologic Neoplasms 52 Endometrial Neoplasms 52 Urinary Bladder Neoplasms 51 Rectal Neoplasms 50

Interventions

Erlotinib Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Liver Cirrhosis × 90 days × Clear all

NCT04172779 2026-05-01

ECHO-B

University of Texas Southwestern Medical Center

Phase 2 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡